(Q46580597)
Statements
1 reference
The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis (English)
1 reference
Bob Löwenberg
1 reference
Pieter Sonneveld
1 reference
Bronno van der Holt
1 reference
Alan K Burnett
1 reference
Wolfgang U Knauf
1 reference
John Shepherd
1 reference
Pier Paolo Piccaluga
1 reference
Gert J Ossenkoppele
1 reference
Gregor E G Verhoef
1 reference
Augustin Ferrant
1 reference
Michael Crump
1 reference
Dominik Selleslag
1 reference
Matthias Theobald
1 reference
Martin F Fey
1 reference
Edo Vellenga
1 reference
Margaret Dugan
1 reference
30 June 2005
1 reference
1 reference
106
1 reference
2646-2654
1 reference
8
1 reference
Identifiers
1 reference
1 reference